Medicine & Life Sciences
Acinetobacter
33%
Anti-Bacterial Agents
80%
Antimicrobial Stewardship
49%
Artificial Respiration
46%
B7-H1 Antigen
27%
Bacteremia
26%
Bronchoalveolar Lavage
18%
Candidemia
24%
Cefepime
25%
Clinical Decision Rules
25%
Cohort Studies
31%
Confidence Intervals
21%
Coronavirus
25%
Critical Care
37%
Critical Illness
78%
Decision Making
28%
Epidemiology
24%
Gram-Negative Bacteria
51%
Gram-Positive Bacteria
22%
Healthcare-Associated Pneumonia
28%
Hospital Mortality
24%
Hospital Rapid Response Team
27%
Immunocompromised Host
20%
Infections
87%
Intensive Care Units
72%
Lung
65%
Lung Transplantation
29%
Meropenem
23%
Methicillin-Resistant Staphylococcus aureus
55%
Microbial Drug Resistance
31%
Mortality
59%
Multiple Drug Resistance
20%
Numbers Needed To Treat
21%
Odds Ratio
23%
Pandemics
18%
Pneumonia
34%
Pseudomonas
21%
Retrospective Studies
19%
Sepsis
89%
Septic Shock
100%
Skilled Nursing Facilities
24%
Smoke
16%
Soft Tissue Infections
23%
Tazobactam Drug Combination Piperacillin
22%
Terminal Care
22%
Therapeutics
26%
Thorax
28%
Transplant Recipients
54%
Vancomycin-Resistant Enterococci
17%
Ventilator-Associated Pneumonia
67%